As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 13, 2012
by Barbara Peters Smith for Herald Tribune
Older patients are not routinely screened for signs of cognitive impairment by their primary care doctors, and the findings of a new study suggests that they should be.
Current guidelines recommend testing brain function only when a patient voices a specific complaint, such as memory lapses. But when veterans 70 and older at the Minneapolis VA Health Care System received brief tests and offers of further evaluation when indicated, new diagnoses of cognitive impairment among them jumped to more than double the previous rate. Mild cognitive impairment — small failures in reasoning and memory — is often but not always a forerunner to dementia.
The study appears in the February issue of the Journal of the American Geriatrics Society. A team led by J. Riley McCarten of the University of Minnesota assessed the effect of screening in patients who were seen in VA primary care clinics and had no indiction of memory loss.
Of 8,342 Veterans offered screening, 97 percent accepted. About 26 percent of those screened failed the first test and 28 percent of them agreed to further evaluation. In that group of 580 veterans, 93 percent were documented to have cognitive impairment, including 75 percent with dementia.
And then there were those who passed the first test but decided to undergo more extensive evaluation. Of those 118 patients, 87 percent were found to have cognitive impairment, including 70 percent with dementia.This suggests that many people suffering from dementia need only be offered an opportunity to seek help.
“Our study demonstrates that proactive strategies such as routine screening are well-accepted and effective in diagnosing cognitive impairment, and that primary care providers value the diagnostic and management services involved,” McCarten said in a statement. “This project has implications for strategies that seek to improve care and contain costs in dementia.”
White women whose genes put them at risk of developing Alzheimer’s disease are more likely than white men with similar risk genes to be diagnosed between the ages of 65 and 75, a study drawing on...
Researchers at the Keck School of Medicine of USC are tackling the sixth-leading cause of death in the United States—Alzheimer’s disease—with a new study that intervenes decades before the disease develops. The school is...
A devastating chronic neurodegenerative disease, Alzheimer’s disease (AD) currently affects around 5.5 million people in the United States alone. Causing progressive mental deterioration, it ultimately advances to impact basic bodily functions such as walking and...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.